Leyla Bozatli

Leyla Bozatli
Faculty of Medicine, Child and Adolescent Psychiatry,
22030 Merkez/Edirne
Turkey

Publications
  • Case Report
    Chill as a Side Effect of Atomoxetine Use: Case Report
    Author(s): Leyla BozatliLeyla Bozatli

    Atomoxetine is a non-stimulatory treatment option with FDA approval for the treatment of ADHD as a selective inhibitor of presynaptic norepinephrine carriers in the central nervous system. The most common side effects reported in children and adolescents are abdominal pain, decreased appetite, vomiting, drowsiness, nervousness, weakness, dizziness, and dyspepsia; other more uncommon side effects are also observed. The treatment of a 7-year-old child diagnosed with ADHD has been replaced with atomoxetine due to loss of appetite and weight loss developing with the initiation of stimulant treatment. A rare chill side effect has been reported after atomoxetine treatment. To our knowledge, this is the first case that atomoxetine-related chill side effect has been reported .. View More»
    DOI: 10.4172/2378-5756.1000403

    Abstract PDF